The challenge of managing coexistent type 2 diabetes and obesity

被引:17
作者
Bailey, Clifford J. [1 ]
机构
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷
关键词
BARIATRIC SURGERY; RECEPTOR AGONIST; GLUCAGON; HYPERGLYCEMIA; THERAPEUTICS; MANAGEMENT; METFORMIN; THERAPY;
D O I
10.1136/bmj.d1996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:8
相关论文
共 34 条
[1]  
[Anonymous], 2009, DIAB ATL
[2]  
[Anonymous], [No title captured]
[3]  
Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
[4]  
Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P20, DOI 10.3132/dvdr.2007.002
[5]   Renal glucose reabsorption inhibitors to treat diabetes [J].
Bailey, Clifford J. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (02) :63-71
[6]  
BEI B, 2009, CELL METAB, V9, P407
[7]   Potential therapies based on antidiabetic peptides [J].
Billyard, Tom ;
McTernan, Philip ;
Kumar, Sudhesh .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) :641-655
[8]   DURATION-1 Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks [J].
Buse, John B. ;
Drucker, Daniel J. ;
Taylor, Kristin L. ;
Kim, Terri ;
Walsh, Brandon ;
Hu, Hao ;
Wilhelm, Ken ;
Trautmann, Michael ;
Shen, Larry Z. ;
Porter, Lisa E. .
DIABETES CARE, 2010, 33 (06) :1255-1261
[9]  
*CONJ, PC DAC EX 4 CJC 1134
[10]   A new glucagon and GLP-1 co-agonist eliminates obesity in rodents [J].
Day, Jonathan W. ;
Ottaway, Nickki ;
Patterson, James T. ;
Gelfanov, Vasily ;
Smiley, David ;
Gidda, Jas ;
Findeisen, Hannes ;
Bruemmer, Dennis ;
Drucker, Daniel J. ;
Chaudhary, Nilika ;
Holland, Jenna ;
Hembree, Jazzminn ;
Abplanalp, William ;
Grant, Erin ;
Ruehl, Jennifer ;
Wilson, Hilary ;
Kirchner, Henriette ;
Lockie, Sarah Haas ;
Hofmann, Susanna ;
Woods, Stephen C. ;
Nogueiras, Ruben ;
Pfluger, Paul T. ;
Perez-Tilve, Diego ;
DiMarchi, Richard ;
Tschoep, Matthias H. .
NATURE CHEMICAL BIOLOGY, 2009, 5 (10) :749-757